UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 


FORM 8-K/A

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

April 24, 2007
Date of Report (Date of earliest event reported)
 

 
NORTH AMERICAN SCIENTIFIC, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
0-26670
51-0366422
(State or other jurisdiction
of
  incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
       
20200 Sunburst Street, Chatsworth, California 91311
(Address of principal executive offices) (Zip Code)

(818) 734-8600
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
 

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
 
 
Explanatory Note

This Amendment to the Current Report on Form 8-K filed by North American Scientific, Inc. on April 30, 2007 is being filed solely to file the exhibit attached hereto as Exhibit 10.1.

Item 9.01       Financial Statements and Exhibits.

(c)
Exhibits

  Exhibit No. Description
     
10.1
Agreement between North American Scientific, Inc. and Michael C. Ryan, dated as of April 24, 2007.
 
 
 

 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
  NORTH AMERICAN SCIENTIFIC, INC.
 
 
 
 
 
 
Date:   December 7, 2007 By:   /s/ John B. Rush
 
Name:   John B. Rush
  Title:   President & Chief Executive Officer